A systematic review to assess adherence and persistence with statins

References

• European Medicines Agency. CPMP draft guidelines on note for guidance on clinical investigation of medicinal products in the treatment of lipid disorders (EMA/CPMP/3020/2003). London: EMEA, 2010
   Google Scholar
• Sharrett AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001;104:1108-13
   PubMed Web of Science ®Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:S1-S45
   PubMed Web of Science ®Google Scholar
• Jacobson TA, Ito MK, Maki KC, et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 – full report. J Clin Lipidol 2015;9:129-69
   PubMed Web of Science ®Google Scholar
• Jellinger PS, Smith DA, Mehta AE, et al. American Association of Clinical Endocrinologists’ Guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract 2012;18(Suppl 1):1-78
   Google Scholar
• Piepoli MF, Hoes AW, Agewall S, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016;37:2315-81
   PubMed Web of Science ®Google Scholar
• Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008;11:44-7
   PubMed Web of Science ®Google Scholar
• Allonen J, Nieminen MS, Lokki M, et al. Mortality rate increases steeply with nonadherence to statin therapy in patients with acute coronary syndrome. Clin Cardiol 2012;35:E22-7
   PubMed Web of Science ®Google Scholar
• Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-30
   PubMed Web of Science ®Google Scholar
• Karmali KN, Lloyd-Jones DM, Berendsen MA, et al. Drugs for primary prevention of atherosclerotic cardiovascular disease: an overview of systematic reviews. JAMA Cardiol 2016;1:341-9
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. The Cochrane Collaboration, 2011 [Last accessed 23 March 2011]
   Google Scholar
• Centre for Reviews and Dissemination. Systematic Reviews: CRD’s guidance for undertaking reviews in health care. York: University of York, 2009 [Last accessed 23 March 2011]
   Google Scholar
• Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998;52:377-84
   PubMed Web of Science ®Google Scholar
• Peterson AM, Nau DP, Cramer JA, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007;10:3-12
   PubMed Web of Science ®Google Scholar
• Degli Esposti L, Saragoni S, Batacchi P, et al. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis. Clin Ther 2012;34:190-9
   PubMed Web of Science ®Google Scholar
• Donnelly LA, Doney AS, Morris AD, et al. Long-term adherence to statin treatment in diabetes. Diabet Med 2008;25:850-5
   PubMed Web of Science ®Google Scholar
• Lachaine J, Rinfret S, Merikle EP, Tarride JE. Persistence and adherence to cholesterol lowering agents: evidence from Regie de l’Assurance Maladie du Quebec data. Am Heart J 2006;152:164-9
   PubMed Web of Science ®Google Scholar
• Leslie RS, Tirado B, Patel BV, Rein PJ. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures. J Manag Care Spec Pharm 2014;20:1193-203
   PubMed Web of Science ®Google Scholar
• McGinnis B, Olson KL, Magid D, et al. Factors related to adherence to statin therapy. Ann Pharmacother 2007;41:1805-11
   PubMed Web of Science ®Google Scholar
• Wiegand P, McCombs JS, Wang JJ. Factors of hyperlipidemia medication adherence in a nationwide health plan. Am J Manag Care 2012;18:193-9
   PubMed Web of Science ®Google Scholar
• Virani SS, Woodard LD, Akeroyd JM, et al. Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clin Cardiol 2014;37:653-9
   PubMed Web of Science ®Google Scholar
• Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007;297:177-86
   PubMed Web of Science ®Google Scholar
• Campione JR, Sleath B, Biddle AK, Weinberger M. The influence of physicians’ guideline compliance on patients’ statin adherence: a retrospective cohort study. Am J Geriatr Pharmacother 2005;3:229-39
   PubMedGoogle Scholar
• Chang CL, Bullano MF, Kamat SA, et al. An assessment of adherence to single-pill versus multi-pill combination lipid-modifying therapies among patients with mixed dyslipidemia in a managed care population. Value Health 2010;13:A169
   PubMed Web of Science ®Google Scholar
• Chodick G, Shalev V, Gerber Y, et al. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel. Clin Ther 2008;30:2167-79
   PubMed Web of Science ®Google Scholar
• Conti D, Lynch K, Dudash K, Scalise L. An evaluation of the impact of statin transition and dose selection on quality metrics in a dual-eligible Medicare D Plan. J Manag Care Pharm 2010;16:518-9;Conference Publication
   Google Scholar
• Couto JE, Panchal JM, Lal LS, et al. Geographic variation in medication adherence in commercial and medicare part D populations. J Manag Care Pharm 2014;20:834-42
   PubMed Web of Science ®Google Scholar
• Patrick AR, Shrank WH, Glynn RJ, et al. The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value Health 2011;14:513-20
   PubMed Web of Science ®Google Scholar
• Pittman DG, Fenton C, Chen W, et al. Relation of statin nonadherence and treatment intensification. Am J Cardiol 2012;110:1459-63
   PubMed Web of Science ®Google Scholar
• Sen D, Rosenstein ED, Kramer N. ANCA-positive vasculitis associated with simvastatin/ezetimibe: expanding the spectrum of statin-induced autoimmunity? Int J Rheum Dis 2010;13:e29-31
   PubMed Web of Science ®Google Scholar
• Korhonen MJ, Ruokoniemi P, Ilomäki J, et al. Adherence to statin therapy and the incidence of ischemic stroke in patients with diabetes. Pharmacoepidemiol Drug Saf 2016;25:161-9
   PubMed Web of Science ®Google Scholar
• Latry P, Molimard M, Dedieu B, et al. Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study. BMC Cardiovasc Disord 2011;11:46
   PubMed Web of Science ®Google Scholar
• Nichol MB, Knight TK, Wu J, et al. Transition probabilities and predictors of adherence in a California Medicaid population using antihypertensive and lipid-lowering medications. Value Health 2009;12:544-50
   PubMed Web of Science ®Google Scholar
• Ruokoniemi P, Korhonen MJ, Helin-Salmivaara A, et al. Statin adherence and the risk of major coronary events in patients with diabetes: a nested case–control study. Br J Clin Pharmacol 2011;71:766-76
   PubMed Web of Science ®Google Scholar
• Kern DM, Balu S, Tunceli O, Anzalone D. Statin treatment patterns and clinical profile of patients with risk factors for coronary heart disease defined by National Cholesterol Education Program Adult Treatment Panel III. Curr Med Res Opin 2014;30:2443-51
   PubMed Web of Science ®Google Scholar
• Ho PM, Magid DJ, Masoudi FA, et al. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC Cardiovasc Disord 2006;6:48
   PubMedGoogle Scholar
• Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J 2008;155:772-9
   PubMed Web of Science ®Google Scholar
• Benson-Davies S, Quigley DR. Food aversions and taste changes following roux-en-y gastric bypass surgery. Topics Clin Nutr 2008;23:357-63
   Google Scholar
• Sanfelix-Gimeno G, Peiro S, Ferreros I, et al. Adherence to evidence-based therapies after acute coronary syndrome: a retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in Valencia, Spain. J Manag Care Pharm 2013;19:247-57
   PubMed Web of Science ®Google Scholar
• Arcoraci V, Santoni L, Ferrara R, et al. Effect of an educational program in primary care: the case of lipid control in cardio-cerebrovascular prevention. Int J Immunopathol Pharmacol 2014;27:351-63
   PubMed Web of Science ®Google Scholar
• Balu S, Simko RJ, Quimbo RM, Cziraky MJ. Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence. Curr Med Res Opin 2009;25:2765-75
   PubMed Web of Science ®Google Scholar
• Burton WN, Chen CY, Schultz AB, Edington DW. The association between achieving low-density lipoprotein cholesterol (LDL-C) goal and statin treatment in an employee population. Popul Health Manag 2010;13:1-8
   PubMed Web of Science ®Google Scholar
• Christian JB, Rabatin V, Lowe KA. Adherence, persistence, and predictors associated with early niacin termination. J Pharm Technol 2013;29:178-85
   Google Scholar
• Cunico C, Picheth G, Correr CJ, Scartezini M. Assessing the adherence to and the therapeutic effectiveness of hypolipidemic agents in a population of patients in Brazil: a retrospective cohort study. Pharm Pract (Granada) 2014;12:378
   PubMedGoogle Scholar
• Ferrajolo C, Arcoraci V, Sullo MG, et al. Pattern of statin use in southern Italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment? PLoS One 2014;9
   PubMed Web of Science ®Google Scholar
• Gibson TB, Mark TL, Axelsen K, et al. Impact of statin copayments on adherence and medical care utilization and expenditures. Am J Manag Care 2006;12:SP11-19
   PubMed Web of Science ®Google Scholar
• Kazerooni R, Watanabe JH, Bounthavong M. Association between statin adherence and cholesterol level reduction from baseline in a veteran population. Pharmacotherapy 2013;33:1044-52
   PubMed Web of Science ®Google Scholar
• Mann DM, Glazer NL, Winter M, et al. A pilot study identifying statin nonadherence with visit-to-visit variability of low-density lipoprotein cholesterol. Am J Cardiol 2013;111:1437-42
   PubMed Web of Science ®Google Scholar
• Pittman DG, Chen W, Bowlin SJ, Foody JM. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Am J Cardiol 2011;107:1662-6
   PubMed Web of Science ®Google Scholar
• Thiebaud P, Patel BV, Nichol MB, Berenbeim DM. The effect of switching on compliance and persistence: the case of statin treatment. Am J Manag Care 2005;11:670-4
   PubMed Web of Science ®Google Scholar
• Vodonos A, Ostapenko I, Toledano R, et al. Statin adherence and LDL cholesterol levels. Should we assess adherence prior to statin upgrade? Eur J Intern Med 2015;26:268-72
   PubMed Web of Science ®Google Scholar
• Watanabe JH, Bounthavong M, Chen T, Ney JP. Association of polypharmacy and statin new-user adherence in a veterans health administration population: a retrospective cohort study. Ann Pharmacother 2013;47:1253-9
   PubMed Web of Science ®Google Scholar
• Wisniowska B, Skowron A. Evaluation of patients’ adherence to statins in Poland. Curr Med Res Opin 2011;27:99-105
   PubMed Web of Science ®Google Scholar
• Wong MC, Jiang JY, Griffiths SM. Adherence to lipid-lowering agents among 11,042 patients in clinical practice. Int J Clin Pract 2011;65:741-8
   PubMed Web of Science ®Google Scholar
• Valdez CA, Ulrich H. Similar medication compliance and control of dyslipidemia with simvastatin or atorvastatin in a staff-model HMO medical clinic. J Manag Care Pharm 2005;11:499-504
   PubMedGoogle Scholar
• Svensson E, Nielsen RB, Hasvold P, et al. Statin prescription patterns, adherence, and attainment of cholesterol treatment goals in routine clinical care: a Danish population-based study. Clin Epidemiol 2015;7:213-23
   PubMed Web of Science ®Google Scholar
• Huser MA, Evans TS, Berger V. Medication adherence trends with statins. Adv Ther 2005;22:163-71
   PubMed Web of Science ®Google Scholar
• Gibson TB, Mark TL, McGuigan KA, et al. The effects of prescription drug copayments on statin adherence. Am J Manag Care 2006;12:509-17
   PubMed Web of Science ®Google Scholar
• Marrs JC, Saseen JJ. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients. Pharmacotherapy 2008;28:562-9
   PubMed Web of Science ®Google Scholar
• Morotti K, Lopez J, Harvey M, et al. Adherence and persistence to statin therapy in a veteran population. Circulation 2014;130:A16924
   Web of Science ®Google Scholar
• Wu J, Seiber E, Lacombe VA, Nahata MC, Balkrishnan R. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes. Ann Pharmacother 2011;45:342-9
   PubMed Web of Science ®Google Scholar
• Robertson TA, Cooke CE, Wang J, et al. Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension. Am J Manag Care 2008;14:710-16
   PubMed Web of Science ®Google Scholar
• Parris ES, Lawrence DB, Mohn LA, Long LB. Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care 2005;28:595-9
   PubMed Web of Science ®Google Scholar
• Nwokeji E, Yarger S, Trice S, et al. Examining medication adherence among tricare beneficiaries receiving statin therapy for secondary prevention of coronary heart disease in military treatment facilities in the United States. Value Health 2011;14:A44
   Web of Science ®Google Scholar
• Summaria F, Ciaralli F, Mustilli M, et al. Pharmacoeconomic impact evaluation of statin adherence in high-risk unselected post myocardial infarction population: an administrative database-guided analysis. Med Arh 2013;67:314-17
   Google Scholar
• Cooke CE, Bresette JL, Khanna R. Statin use in American Indians and Alaska natives with coronary artery disease. Am J Health Syst Pharm 2006;63:1717-22
   PubMed Web of Science ®Google Scholar
• Rosenbaum D, Dallongeville J, Sabouret P, Bruckert E. Discontinuation of statin therapy due to muscular side effects: a survey in real life. Nutr Metab Cardiovasc Dis 2013;23:871-5
   PubMed Web of Science ®Google Scholar
• Kahya Eren N, Harman E, Dolek D, et al. The gap between the current dyslipidemia guidelines and the physicians’ treatment targets in patients with type 2 diabetes in Turkey. Minerva Cardioangiol 2014;62:287-95
   PubMed Web of Science ®Google Scholar
• Reiner Z, De Backer G, Fras Z, et al. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries – findings from the EUROASPIRE IV survey. Atherosclerosis 2016;246:243-50
   PubMed Web of Science ®Google Scholar
• Colivicchi F, Ansalone G, Tubaro M, et al. Initial prescription and persistence of intensive lipid-lowering therapy after acute coronary syndromes: insights from the NET-SCA prospective registry. Eur Heart J 2013;34:164
   PubMed Web of Science ®Google Scholar
• Perreault S, Blais L, Lamarre D, et al. Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention. Br J Clin Pharmacol 2005;59:564-73
   PubMed Web of Science ®Google Scholar
• Lindgren P, Eriksson J, Buxton M, et al. The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial. Int J Clin Pract 2010;64:1228-34
   PubMed Web of Science ®Google Scholar
• Holme I, Szarek M, Cater NB, et al. Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study. Eur J Cardiovasc Prev Rehabil 2009;16:315-20
   PubMedGoogle Scholar
• Wei L, Fahey T, MacDonald TM. Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome. Br J Clin Pharmacol 2008;66:110-16
   PubMed Web of Science ®Google Scholar
• Corrao G, Conti V, Merlino L, et al. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. Clin Ther 2010;32:300-10
   PubMed Web of Science ®Google Scholar
• Bouchard MH, Dragomir A, Blais L, et al. Impact of adherence to statins on coronary artery disease in primary prevention. Br J Clin Pharmacol 2007;63:698-708
   PubMed Web of Science ®Google Scholar
• Blackburn DF, Dobson RT, Blackburn JL, Wilson TW. Cardiovascular morbidity associated with nonadherence to statin therapy. Pharmacotherapy 2005;25:1035-43
   PubMed Web of Science ®Google Scholar
• Rublee DA, Chen S-Y, Mardekian J, et al. Evaluation of cardiovascular morbidity associated with adherence to atorvastatin therapy. Am J Ther 2012;19:24-32
   PubMed Web of Science ®Google Scholar
• Shaya FT, Gu A, Yan X. Effect of persistence with drug therapy on the risk of myocardial re-infarction. Pharmacy and therapeutics 2008;33:288-95
   Google Scholar
• Penning-van Beest FJ, Termorshuizen F, Goettsch WG, et al. Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study. Eur Heart J 2007;28:154-9
   PubMed Web of Science ®Google Scholar
• Hinchliffe A. Patient Adherence to Treatment with Statins for the Prevention of Cardiovascular Disease. Cardiff: Public Health Wales, 2011 [Last accessed 6 November 2015] Available from: http://www.wales.nhs.uk/sites3/documents/490/Adherence%20with%20statins%20to%20prevent%20CVD-%20literature%20review%202011%20v1%200.pdf
   Google Scholar
• Bellows BK, Olsen CJ, Voelker J, Wander C. Antihyperlipidemic medication treatment patterns and statin adherence among patients with ASCVD in a managed care plan after release of the 2013 ACC/AHA guideline on the treatment of blood cholesterol. J Manag Care Spec Pharm 2016;22:892-900
   PubMed Web of Science ®Google Scholar
• Simpson Jr RJ, Mendys P. The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review. J Clin Lipidol 2010;4:462-71
   PubMed Web of Science ®Google Scholar
• Helin-Salmivaara A, Lavikainen PT, Korhonen MJ, et al. Pattern of statin use among 10 cohorts of new users from 1995 to 2004: a register-based nationwide study. Am J Manag Care 2010;16:116-22
   PubMed Web of Science ®Google Scholar
• Public Health Wales. Patient adherence to treatment with statins for the prevention of cardiovascular disease. Cardiff: Public Health Wales NHS Trust, 2011 [Last accessed 6 November 2015]
   Google Scholar
• De Vera MA, Bhole V, Burns LC, Lacaille D. Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review. Br J Clin Pharmacol 2014;78:684-98
   PubMed Web of Science ®Google Scholar
• Joanna Briggs Institute. The Joanna Briggs Institute critical appraisal tools for use in JBI systematic reviews: checklist for systematic reviews and research syntheses. Adelaide: The University of Adelaide, 2016 http://joannabriggs.org/assets/docs/critical-appraisal-tools/JBI_Critical_Appraisal-Checklist_for_Systematic_Reviews.pdf [Last accessed 5 January 2017]
   Google Scholar
• Song F, Hooper L, Loke YK. Publication bias: what is it? How do we measure it? How do we avoid it? Open Access J Clin Trials 2013;5:71-81
   Google Scholar